Chasing the Yield
Investing for income through dividends and distributions
-
Owl Rock Capital authorizes $100 million stock repurchase program
In a letter to shareholders dated November 5, 2021 Owl Rock Capital (ORCC) announced they authorized up to $100 million in stock buybacks and that the plan commenced on November 2, 2021. In accordance with Section 23(c)(1) under the Investment Company Act of 1940, please be advised that the Board ofDirectors of Owl Rock Capital…
-
J splits with J
J&J will split in two, Shell will consolidate into one, gold hits new highs and much more!
-
Johnson & Johnson to split into two companies
No word yet on how this will affect stockholders and the dividend. Johnson & Johnson JNJ 1.19% plans to break up into two companies, splitting off the $15-billion-a-year division that sells Band-Aid bandages, Tylenol medicines and Johnson’s Baby Powder in a shift indicating just how much healthcare has changed since the company helped pioneer the industry. The world’s largest health-products company by sales will…
-
Price of oil continues to be a problem for the United States and President Biden
Rising oil prices have handed President Biden a dilemma at a politically precarious time. His administration’s ambitious agenda to stem global warming calls for a shift away from fossil fuels. Yet Mr. Biden is now urging the Organization of the Petroleum Exporting Countries to increase production to ease shortages and lower prices. OPEC has so…
-
Inflation hits 30 year high
Inflation seems to be less and less “transitory”. I still believe things will settle down into 2022 but this kind of news has a way of snowballing. With expectations goes the economy in many ways. U.S. inflation hit a three-decade high in October—rising at a 6.2% annual rate—as pandemic-related supply shortages and continued strength in…
-
Oklahoma court overturned ruling against Johnson & Johnson
In its ruling Tuesday, the state Supreme Court took issue with the lower court’s application of the state’s public nuisance law, arguing it doesn’t cover the “manufacturing, marketing and the selling of prescription opioids.” The lawsuit was the first trial in the nation that sought to hold the pharmaceutical industry accountable for widespread opioid addiction and overdoses.…